Open AccessP508: REAL LIFE EXPERIENCE USING FRONT‐LINE CPX‐351 FOR THERAPY‐RELATED AND AML‐MRC: RESULTS FROM THE SPANISH PETHEMA REGISTRY.
Author(s) -
Bernal T.,
Rad G.,
Laiglesia A.,
Benavente C.,
Garcia Noblejas A.,
Garcia Belmonte D.,
Riaza R.,
Salamero O.,
Foncillas A.,
Roldán A.,
Noriega Concepcion V.,
Perez de Oteyza J.,
Bergua Burgues J. M.,
Lorente de Uña S.,
Fuente Burguera A.,
Garcia Perez M. J.,
Lopez Lorenzo J. L.,
Martinez P.,
Alaez C.,
Callejas M.,
Martinez Chamorro C.,
Rifon Roca J.,
Amador Barciela L.,
Lopez M.,
Gomez Correcha K.,
Lavilla Rubiera E.,
Amigo M. L.,
VallLlovera F.,
Garrido A.,
Garcia Fortes M.,
Miguel Llorente D.,
Aules Leonardo A.,
Cervero C.,
Coll Jorda R.,
Perez Encinas M.,
Polo Zarzuela M.,
Martinez Cuadron D.,
Montesinos P.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000844920.74396.35
Subject(s) - medicine , cytarabine , adverse effect , chemotherapy regimen , hematopoietic stem cell transplantation , clinical endpoint , oncology , anthracycline , transplantation , chemotherapy , surgery , clinical trial , cancer , breast cancer